Acorda Therapeutics, Inc.

Acorda Therapeutics, Inc. is a leading biotechnology company dedicated to developing innovative therapies that restore neurological function and improve the lives of individuals with neurological disorders. Since its inception, Acorda Therapeutics has been committed to advancing medical science through research, development, and collaboration with the patient, medical, and scientific communities.

Located at 2 Blue Hill Plaza, 3rd Fl, Pearl River, New York 10965, US, with an additional location at 190 Everett Avenue, Chelsea, MA 02150, US, Acorda Therapeutics is focused on making a significant impact on patient care. The company invests heavily in research and development, fostering a dynamic environment and a strong corporate culture that attracts top talent. Acorda Therapeutics' dedication has positioned it as a potential industry leader, ready for continued growth and innovation.

Acorda Therapeutics, Inc. is known for its commitment to developing and commercializing therapies that improve the lives of people affected by nervous system disorders, including multiple sclerosis (MS), spinal cord injury (SCI), stroke, and epilepsy. Acorda Therapeutics is also developing a therapeutic approach for chronic heart failure. We invite the management team at Acorda Therapeutics, Inc. to create a customized and exclusive company showcase and product listing on our platform.